NCT04669301
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 65 Years and older (Older Adult)
Location of Metastases: 
Additional Notes: 
Exclusions: Patients under the age of 65 years old; Breast cancer patients receiving endocrine therapy as their only systemic therapy
https://ClinicalTrials.gov/show/NCT04669301